Cue Health Inc.

HLTHDelisted Jun 28, 2024

Industry: Laboratory Analytical Instruments
SEC CIK: 0001628945

SEC filings (opens in a new tab)

Cue Health Inc. was delisted on Jun 28, 2024; its insiders filed their last Form 4 on Aug 27, 2024; 58 institutions reported holding it in 13F filings for Q1 2024, worth $13.8M in total; no superinvestor held it.

Key figures

Market cap: –; Not available
Insider buys: 0; Open market, last 90 days
Insider sells: 0; Open market, last 90 days
13F holders: 58; Q1 2024, −5 vs. previous quarter
13F value: $13.8M; Reported value at the end of Q1 2024
Superinvestors holding: 0; At the end of Q1 2024

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2023: $70.9M; −85.3% year over year
Net income, FY2023: -$373.5M; No comparable prior period
Free cash flow, FY2023: -$147.0M; No comparable prior period
Revenue, Q4 FY2023: $18.8M; −87.2% year over year

Revenue flow, FY2023

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2023: $373.5M (526.5% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 2.24K; Shares sold short
Change: −6.36K; −73.9% vs. previous
Days to cover: 1.00; At average daily volume

Superinvestors holding HLTH, Q1 2024

Go to the superinvestors tab

No superinvestor reported holding HLTH at the end of Q1 2024.

Latest insider trades

See all insider trades

Open-market purchases and sales by Cue Health Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Aug 27, 2024 (view filing)8:07 PM ET	Aug 23	4 days	Tarsadia Capital, LLC and 8 others10% Owner	SSaleCommon stock, par value $0.00001 per share ("Common Stock")	−10.7M	$0.0001	−$1.07K	−100.0%0 after
Aug 27, 2024 (view filing)8:07 PM ET	Aug 23-27	4 days	Tarsadia Capital, LLC and 8 others10% Owner	SSale	−7.62M	$0.00	$0	−100.0%0 after	3 lots
Dec 9, 2022 (view filing)8:32 PM ET	Dec 8	1 day	Sever ClintChief Product Officer	SSale	−29.3K	$3.02	−$88.3K	−0.7%3.94M after
Dec 7, 2022 (view filing)9:11 PM ET	Dec 6-7	1 day	Sever ClintChief Product Officer	SSale	−50.8K	$3.06	−$155.7K	−1.3%3.94M after	2 lots
Dec 1, 2022 (view filing)7:31 PM ET	Nov 30	1 day	Sever ClintChief Product Officer	SSale	−22.7K	$3.11	−$70.7K	−0.6%3.95M after
Nov 25, 2022 (view filing)6:07 PM ET	Nov 22-25	3 days	Sever ClintChief Product Officer	SSale	−57.3K	$2.54	−$145.5K	−1.4%3.95M after	3 lots
Nov 10, 2022 (view filing)9:03 PM ET	Nov 8-10	2 days	Sever ClintChief Product Officer	SSale	−80.0K	$3.83	−$306.1K	−2.0%3.95M after	3 lots
Oct 27, 2022 (view filing)9:19 PM ET	Oct 25-27	2 days	Sever ClintChief Product Officer	SSale	−80.0K	$3.61	−$289.0K	−2.0%3.95M after	3 lots
Oct 13, 2022 (view filing)8:03 PM ET	Oct 11-13	2 days	Sever ClintChief Product Officer	SSale	−80.0K	$3.29	−$262.9K	−2.0%3.95M after	3 lots
Oct 3, 2022 (view filing)8:33 PM ET	Sep 30	3 days	Sever ClintChief Product Officer	SSale	−7.37K	$3.03	−$22.3K	−0.2%3.95M after

Top 10 13F holders, Q1 2024

See all 58 holders

The largest institutional positions in Cue Health Inc. at the end of Q1 2024; share changes are against Q4 2023.

Institutions holding HLTH in Q1 2024
Institution	Shares	Value	% of portfolio	Change in shares	Action
SherpaCapital, LLC	15,240,546	$2.88M	4.99%	00.0%	Unchanged
Tarsadia Capital, LLC	10,684,791	$2.02M	6.24%	00.0%	Unchanged
Oakmont Corp	9,595,348	$1.81M	0.44%	00.0%	Unchanged
Decheng Capital LLC	8,980,909	$1.70M	0.23%	00.0%	Unchanged
Madrone Advisors, LLC	7,078,566	$1.34M	0.18%	00.0%	Unchanged
Jabodon PT Co	3,981,258	$751.0K	0.53%	00.0%	Unchanged
Vanguard Group Inc	3,884,285	$732.6K	0.00%	00.0%	Unchanged
Temasek Holdings (Private) Ltd	3,125,000	$589.4K	0.00%	00.0%	Unchanged
Goldman Sachs Group Inc	2,850,551	$537.6K	0.00%	−1,076,339−27.4%	Reduced
BlackRock Inc.	1,561,931	$294.6K	0.00%	−10,654−0.7%	Reduced